Evaluating the efficacy of neoadjuvant immunotherapy combined with chemotherapy for stage IIIa non-small cell lung cancer

Evaluating the efficacy of neoadjuvant immunotherapy combined with chemotherapy for stage IIIa non-small cell lung cancer

Abstract The prognosis for stage IIIa non-small cell lung cancer (NSCLC) remains poor, necessitating innovative treatment strategies to improve patient outcomes. This study evaluates the efficacy of neoadjuvant immunotherapy combined with chemotherapy in enhancing resection rates, survival, and prog...

Full description

Saved in:
Bibliographic Details
Main Authors: Ruiqiang Song, Zhixiang Chen, Tianxi Zheng, Jingfei Huang, Yanbo Cheng
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Neoadjuvant immunotherapy
Lung cancer
Non-small cell lung cancer
Overall survival
Online Access:https://doi.org/10.1038/s41598-025-13917-0
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-13917-0

Similar Items